• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
Are we prescribing antibiotics wrong?

Are we prescribing antibiotics wrong?

The message has always been clear: make sure to finish your full course of antibiotics. Or else? Risk the development of antibiotic resistance - a...
Outsourcing Clinical Trials Outside of the US

Outsourcing Clinical Trials Outside of the US

Outsourcing clinical trials has been a subject of both controversy and relevance in the pharmaceutical community. It is an important part of drug...
Regulators And Standards Groups Take Steps To Address Emerging Technologies In Biopharma

Regulators And Standards Groups Take Steps To Address Emerging Technologies In Biopharma

Last year was a banner year for new drugs, with 46 new molecular entities approved by the FDA, compared to 22 in 2016. 2017 also saw the approval of...
Two-dimensional liquid chromatography with multiple heart-cutting

Two-dimensional liquid chromatography with multiple heart-cutting

Two-dimensional liquid chromatography (2D-LC) has obtained increasing focus over the past two decades. At LEO Pharma, we continuously evaluate new...
Understanding Pharmaceutical Logistics Validation in a Dynamic Environment

Understanding Pharmaceutical Logistics Validation in a Dynamic Environment

Applying validation standards to bio/pharmaceutical logistics, the science of transporting bio/analytical, clinical and manufactured product, is an...
Are we prescribing antibiotics wrong?
Are we prescribing antibiotics wrong?
Outsourcing Clinical Trials Outside of the US
Outsourcing Clinical Trials Outside of the US
Regulators And Standards Groups Take Steps To Address Emerging Technologies In Biopharma
Regulators And Standards Groups Take Steps To Address Emerging Technologies In Biopharma
Two-dimensional liquid chromatography with multiple heart-cutting
Two-dimensional liquid chromatography with multiple heart-cutting
Understanding Pharmaceutical Logistics Validation in a Dynamic Environment
Understanding Pharmaceutical Logistics Validation in a Dynamic Environment

Latest White Papers

  • Random

Latest News

  • Title
  • Most Views
  • Recently Added
  • Ordering
  • Random
Load More
Load More
Dermal filler, a product candidate currently under development

CollPlant Biotechnologies , or 'CollPlant', a regenerative and aesthetics medicine company ...

Prospera SCS Stimulator

BIOTRONIK Neuro will unveil new data from the BENEFIT-03 clinical study. The findings highlight the ...

A collage of images of various body parts

Zymo Research is proud to introduce the Master the Microbiome Grant, a global initiative dedicated ...

Andri Lemarquis, M.D., Ph.D., City of Hope staff

A team of international researchers led by scientists at City of Hope, one of the largest and most ...

Load More
Load More
Load More

Latest Updates

Avanzanite Bioscience B.V., a pioneering commercial-stage specialty pharmaceutical company advancing life-changing medicines for rare disease patients across Europe, announces the appointment of ...

Avanzanite Bioscience B.V., a pioneering commercial-stage specialty pharmaceutical company advancing life-changing medicines for rare disease patients across Europe, announces the appointment of Abdelghani (Abdel) Omari as its first-ever Chief Financial Officer (CFO).

This milestone appointment ...

Vertex Pharmaceuticals Incorporated announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigine), an oral, non-opioid, highly selective NaV1.8 pain signal inhibitor ...

Vertex Pharmaceuticals Incorporated announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigine), an oral, non-opioid, highly selective NaV1.8 pain signal inhibitor for the treatment of adults with moderate-to-severe acute pain. JOURNAVX is an effective, ...

Beckman Coulter Diagnostics, a global leader in clinical diagnostics, announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Beckman Coulter's Access ...

Beckman Coulter Diagnostics, a global leader in clinical diagnostics, announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Beckman Coulter's Access p‑Tau217/β-Amyloid 1-42 plasma ratio. This blood test is designed to aid healthcare providers identify ...

Young Pharmaceuticals, Inc., a leading provider of physician-dispensed skincare products, announces an exclusive distribution agreement with LAC2βiome S.r.l., a maker of microbial based product ...

Young Pharmaceuticals, Inc., a leading provider of physician-dispensed skincare products, announces an exclusive distribution agreement with LAC2βiome S.r.l., a maker of microbial based product solutions in Milan, Italy.

The product line offers a science-driven approach to improving skin ...

Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has announced the development and upcoming launch of the new version of its proprietary V-OVS® syringe closure ...

Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has announced the development and upcoming launch of the new version of its proprietary V-OVS® syringe closure system.

The new closure, V-OVS® next, will further advance a proprietary system with many years ...

Yamaha Motor Co., Ltd. (Tokyo: 7272) announced that it will exhibit the CELL HANDLER™ 2, a cell picking and imaging system, at marking the product's first overseas exhibition.

At the exhibition, ...

Yamaha Motor Co., Ltd. (Tokyo: 7272) announced that it will exhibit the CELL HANDLER™ 2, a cell picking and imaging system, at marking the product's first overseas exhibition.

At the exhibition, Yamaha Motor will showcase the CELL HANDLER™ 2 in action. Additionally, the Dutch-based ...